Granisetron Hydrochloride Injection, Solution
Product Images NDC 55150-175

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Granisetron Hydrochloride (NDC 55150-175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (1 mg (base) per mL)

Package Label-principal Display Panel (1 mg (base) per mL)
This is a description for a medication with the National Drug Code 55150-175-01. The medication should only be used for intravenous purposes, and the text indicates that the medication is in a 1mL single-use vial with a dosage of 1 mg per mL. The medication should be stored between 20° to 25°C (68° to 77°F) and should not be frozen or exposed to light. Any unused portion should be discarded. The manufacturer of the medication is AuroMedics Pharma LLC, and it was manufactured in India.*
FDA Label Image

Package Label-principal Display Panel (1 mg (base) per mL)

Package Label-principal Display Panel (1 mg (base) per mL)
This is a description of an injectable medication called Granisetron Hydrochloride, with a concentration of 1 mg per mL. The solution comes in a single-use vial that should only be used intravenously. The vial is sterile, and each mL of solution contains 1.12 mg of granisetron hydrochloride USP. The medication also contains other ingredients such as sodium chloride, methparzben, and propylparaben. The vial should be stored at 20°C to 25%, and the stopper is not made of natural rubber. The usual dosage should be determined by the prescribing doctor, as explained in the package insert included with the medication. The distributor of this medication is AuroMedics Prama L1.*
FDA Label Image

Package Label-principal Display Panel (4 mg per 4 mL (1 mg (base)/mL))

Package Label-principal Display Panel (4 mg per 4 mL (1 mg (base)/mL))
Granisetron is a medication that should not be frozen and needs to be protected from light. It is distributed by AuroMedics Pharma LLC and made in India. The package contains 4mg per 4ml of Granisetron. The product is intended for intravenous use only and has a NDC code of 55150-176-04. The usual dosage should be determined by referring to the package insert. The drug should be stored at a temperature of 20°C to 25°C (68°F to 77°F).*
FDA Label Image

Package Label-principal Display Panel (4 mg per 4 mL (1 mg (base)/mL))

Package Label-principal Display Panel (4 mg per 4 mL (1 mg (base)/mL))
This is a description of a medication called Granisetron Hydrochloride Injection. Each 4 mL vial contains 4 mg of Granisetron Hydrochloride USP, which is equivalent to 1 mg (base)/mL. It is intended for intravenous use only and is sterile. Each mL of the solution contains 1.12 mg of Granisetron Hydrochloride USP, 9 mg of Sodium Chloride, 2 mg of Methylparaben, 1.8 mg of Propylparaben, and other preservatives. The medication should be stored at 20°C to 25°C, protected from light and not frozen. The medication is distributed by AuroMedics Pharma LLC. No information about the recommended dosage is included in the text.*
FDA Label Image

Granisetron Hydrochloride Chemical Structure (Granisetron Str)

Granisetron Hydrochloride Chemical Structure (Granisetron Str)
The text appears to be a chemical formula for "granisetron hydrochloride." It is commonly used as an anti-nausea medication during cancer treatment and other medical procedures that may cause nausea and vomiting.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.